ISSCR Founder Leonard Zon talks about the development and growth of the ISSCR and

Leonard Zon

ISSCR Founder

Understanding the Clinical Applications of MSCs

Megan Munsie, PhD, University of Melbourne and Mark Young, MBBS, FACSEP, University of Queensland

'Know Thy Cell' - Rigorous Assays for the Characterization of MSCs

Moustapha Kassem, MD, PhD, University Hospital of Odense

Tissue Specific Stem / Progenitor Cells Known as MSCS

Pamela Robey, PhD, National Institutes of Health

Cell Therapy Regulations in the U.S.

Joyce Frey-Vansconcells, PhD, Frey-Vasconcells Consultants LLC and Lei Xu, MD, PhD, U.S. FDA

Japan's Regulatory Framework for Expedited Clinical Application of Cell-Based Therapeutic Products

Yoji Sato, PhD, National Institutes of Health Sciences (Japan)

Using Imaging Technologies to Understand Mechanism of Action, Safety and Efficacy of Cellular Therapies

Bill Shingleton, PhD, GE Healthcare and Greg Mullen, PhD, King's College London

Developing Standards for Cell Therapy and Regenerative Medicine

Judith Arcidiacono, MS, U.S. FDA and Sheng Lin-Gibson, PhD, National Institute of Standards and Technology (U.S.)

Cell Therapy Process Development and Process Changes

Ian Harris, PhD, Janssen Research and Development, LLC and Thomas Finn, PhD, U.S. FDA

Preclinical Development for Cell Therapy Products

Jane Lebkowski, PhD, Asterias Therapeutics and Iwen Wu, PhD, U.S. FDA